ATORVO+

Chemical preparations for pharmaceutical or medical purposes, namely, for lipid diseases and disorders; Cholesterol reducers; Pharmaceutical preparations for the treatment and prevention of dysregulation of cholesterol metabolism, myositis, rhabdomyolysis, or statin-associated myopathy; Pharmaceutical preparations for the treatment and prevention of hyperlipidemia, hypercholesteremia, or atherosclerosis; Pharmaceuticals, namely, lipid lowering agents